Ellen Rose
Investor Relations Contact presso LYELL IMMUNOPHARMA, INC.
Profilo
Ellen Rose is currently the Senior VP-Communications & Investor Relations at Lyell Immunopharma, Inc. She previously worked as the Director-Communications at ALZA Corp.
and as the Head-Communications & Media Relations at Prothena Corp.
Plc.
Ms. Rose completed her undergraduate degree at Stanford University.
Posizioni attive di Ellen Rose
| Società | Posizione | Inizio |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Investor Relations Contact | 01/04/2021 |
Precedenti posizioni note di Ellen Rose
| Società | Posizione | Fine |
|---|---|---|
| ALZA CORPORATION | Public Communications Contact | - |
| PROTHENA CORPORATION PLC | Public Communications Contact | - |
Formazione di Ellen Rose
| Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
- Borsa valori
- Insiders
- Ellen Rose
